Brief: PCI Biotech and Ultimovacs initiates preclinical research collaboration
Jan 27 (Reuters) - Pci Biotech Holding Asa PCIB.OL :
* PCI Biotech and Ultimovacs initiates preclinical research
collaboration
* Purpose of collaboration is to utilize companies'
complementary scientific platforms to explore potential
synergies
Source text for Eikon: ID:nHUG20vcpc
Further company coverage: PCIB.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on PCI Biotech Holding ASA
See all newsBrief: Euronext Oslo Børs To Delist PCI Biotech Holding Shares
Brief: Euronext Oslo Børs Gets Application From PCI Biotech Holding For Delisting
Brief: PCI Biotech Holding Board Proposes Dissolution, Delisting
Brief: Oslo Bors: PCI Biotech Holding Is Placed In Recovery Box
Brief: PCI Biotech Says Co Initiates Process To Evaluate Opportunity For Structured Wind-Up Process